EichorEICHOR
Location: Guiyang Synced from ClinicalTrials.gov · August 07, 2026

Clinical studies recruiting near Guiyang

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line
Phase 3 · The Affiliated Hospital of Guizhou Medical University ( Site · Merck Sharp & Dohme LLC · NCT06136559
Evaluation of Rovadicitinib Compared to the Protocol Selected by Researchers in Third Line and Subsequent Studies of Mod
Phase 3 · The Affiliated Hospital of Guizhou Medical University · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT06682169
IDEAL Study: Blinded RCT for the Impact of AI Model for Cerebral Aneurysms Detection on Patients' Diagnosis and Outcomes
NA · Guizhou Provincial People's Hospital · Jinling Hospital, China · NCT06118840
A Study of TQB2102 for Injection in the Treatment of HER2-positive Biliary Tract Cancer
Phase 1/Phase 2 · The Affiliated Hospital of Guizhou Medical University · Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharm · NCT06431490
Artificial Intelligence-driven Virtual Standardized Pediatric Patients Trial
NA · Yuntan Street Community Health Center · Southern Medical University, China · NCT06699433
The Chinese Familial Alzheimer's Network
Phase N/A · The Affiliated Hospital Of Guizhou Medical University · Capital Medical University · NCT03657732
Phase II/III Study of SPH4336 Combined With Letrozole vs Placebo Combined With Letrozole in First-line Treatment of Brea
Phase 2/Phase 3 · The Affiliated Cancer Hospital of Guizhou Medical University · Shanghai Pharmaceuticals Holding Co., Ltd · NCT05744687
Chinese Adults With Kidney Disease
Phase 2 · ADARx Clinical Site · ADARx Pharmaceuticals, Inc. · NCT07522099
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Phase 3 · Guizhou Provincial People's Hospital · Gilead Sciences · NCT06051617
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
Phase N/A · Research Site · AstraZeneca · NCT06465810
China HeadAche DIsorders RegiStry
Phase N/A · The Second People's Hospital of Guiyang · Beijing Tiantan Hospital · NCT05334927
A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropath
Phase 3 · The Affiliated Hospital of Guizhou Medical University · Biogen · NCT06962800
Clinical Study on the Efficacy and Safety of TNTL in the Treatment of Non-proliferative Diabetic Retinopathy
Phase 3 · The First Affiliated Hospital of Guizhou University of Tradi · Beletalent (Zhuhai) Pharmaceutical Co., Ltd · NCT06817265
Reduced-dose Radiotherapy for Stage III Nasopharyngeal Carcinoma Based on the Treatment Response
Phase 3 · Cancer Hospital of Guizhou Medical University · Sun Yat-sen University · NCT06239727
Study of the Key Techniques of Prevention and Treatment of Osteoporotic Refracture
NA · Affiliated Hospital of Guizhou Medical University · Peking Union Medical College Hospital · NCT05866029
A Study of Lianxiaxiaopi Granules in the Treatment of Postprandial Distress Syndrome
Phase 3 · The First Affiliated Hospital of Guizhou University of Tradi · Tasly Pharmaceutical Group Co., Ltd · NCT06696261
REmimazolam vs Propofol Total Intravenous Anesthesia on Outcomes After Major Noncardiac SurgEry
Phase 4 · The Affiliated Hospital of Guizhou Medical University · Nanfang Hospital, Southern Medical University · NCT05728775
Prediction of Peritoneal Metastasis for Gastric Cancer Based on Radiomics
Phase N/A · Guizhou Provincial People's Hospital · Chinese Academy of Sciences · NCT05722275
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel
Phase 3 · People's Hospital of Guizhou Province /ID# 243614 · AbbVie · NCT04928846
A Study of MI078 for Postpartum Depression
Phase 3 · Guizhou Provincial People's Hospital · Nanjing Minova Pharmaceutical Co., Ltd. · NCT07721961
Clinical Trial Comparing TQB2868 Injection Combined With Anlotinib Hydrochloride Capsules With Placebo Combined With Che
Phase 3 · Guizhou Medical University Affiliated Cancer Hospital Co., L · Shanghai Chia Tai Tianqing Pharmaceutical Technology Develop · NCT07165951
Clinical Study on the Efficacy and Safety of LM-302 Injection Combined With Tislelizumab and Tislelizumab Combined Chemo
Phase 3 · The People's Hospital of Guizhou Province · Shanghai Chia Tai Tianqing Pharmaceutical Technology Develop · NCT07385703
Treatment of Vasospasm of Aneurysmal Subarachnoid Hemorrhage With Intrathecal Nicardipine - FAST-IT Trial
NA · Jinyang Hospital Affiliated to Guizhou Medical University · The Affiliated Hospital Of Guizhou Medical University · NCT06329635
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of
Phase 3 · Research Site · AstraZeneca · NCT06921785
Newly-diagnosed Pediatric Ph-positive B-ALL Protocol
Phase 3 · The Affiliated Hospital of Guizhou Medical University · Institute of Hematology & Blood Diseases Hospital, China · NCT07152041
A Phase Ⅰb/Ⅱa Clinical Study of IMC-003 Injection for the Treatment of Pulmonary Arterial Hypertension Receiving Backgro
Phase 1/Phase 2 · The Affiliated Hospital of Guizhou Medical University · ImmuneCare Biopharmaceuticals (Shanghai) Co., Ltd. · NCT07593027
ctDNA-MRD Guided Escalation of Ivonescimab and Docetaxel in Advanced NSCLC With Long-Term Responses to First-line Immuno
Phase 2 · Guiyang Public Health Clinical Center · Second Xiangya Hospital of Central South University · NCT06951646
An Exploratory Study of Individualized Neo-antigen mRNA Cancer Vaccine InnoPCV in Advanced Solid Tumor Treatment
EARLY_Phase 1 · The Affiliated Hospital of Guizhou Medical University · The Affiliated Hospital Of Guizhou Medical University · NCT06497010
Comparing Modified XELOX Plus Sintilimab With Standard XELOX Plus Sintilimab in First-line Treatment for HER2-negative G
Phase 3 · The Affliated Cancer Hospital of Guizhou Medical University · Sun Yat-sen University · NCT05918094
Research on the Mechanism Affecting Progression of Bronchiectasis
Phase N/A · Guizhou Provincial people's Hospital · Union Hospital, Tongji Medical College, Huazhong University · NCT05731427
Look up another city
Look up another condition